Stem cells are derived from thehuman cells. Stem cell therapy is also known as regenerative medicine. Thetherapy has the ability to regenerate human cells, tissues, or organs, in orderto restore normal functioning of the body. Stem cell therapies are used in thetreatment of spinal cord injury, Parkinson’s disease, sickle cell disease,diabetes, and heart diseases.
Statistics:
The global stemcells market is estimated to account for US$ 9,941.2 Mn in terms of valuein 2020 and is expected to reach US$ 18,289.9 Mn by the end of 2027.
Global Stem Cells Market: Drivers
Increasing adoption of stem cellsfor the treatment of various diseases is expected to propel growth of theglobal stem cells market over the forecast period. For instance, in June 2019,Personalized Stem Cells, Inc. submitted an Investigational New Drug Application(IND) to the U.S. FDA for utilizing patients own adipose-derived stem cells totreat their osteoarthritis.
Global Stem Cells Market:Opportunities
R&D in stem cells is expectedto offer lucrative growth opportunities for players in the global stem cellsmarket. For instance, in January 2020, researchers at Biomedical ResearchInstitute, MEDIPOST Co., Ltd., South Korea, reported analysis of the effects ofspheroid umbilical cord blood-derived mesenchymal stem cells (MSCs) andsuggested a new therapeutic approach, 3D spheroid formation of MSCs, in orderto enhance the regeneration process in the course of osteoarthritis.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/4222
Global Stem Cells Market:Restraints
Government regulations againstunethical harvesting of stem cells are expected to hinder growth of the globalstem cells market. For instance, in the U.S., the ban on federal funding hadbeen imposed since 1974, and was lifted as late as 2009. Ban has also beenenforced in certain European nations such as Germany, Austria, Portugal andItaly and some Asian nations such as China, South Korea and Israel.
Key Takeaways:
The global stem cells market wasvalued at US$ 9,112.0 Mn in 2019 and is forecast to reach a value of US$18,289.9 Mn by 2027 at a CAGR of 9.1% between 2020 and 2027. Major factordriving the growth of global stem cells market during the forecast periodinclude increasing research and development, and increasing applications ofregenerative medicine.
Adult stem cells held dominantposition in the global stem cells market in 2019, accounting for 81.2% share interms of value, followed by Human Embryonic Stem Cells and Induced PluripotentStem Cells, respectively. Increasing use of adult stem cells in regenerativemedicine is supporting growth of the segment.
Market Trends
Adoption of stem cells in R&Dis expected to propel growth of the global stem cells market. For instance, inDecember 2019, in the journal Cell Reports, researchers from the University ofCalifornia Los Angeles reported development of accurate model of organ scarringusing stem cells in a lab.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/stem-cells-market-4222
Moreover, approval and launch ofnovel CAR-T therapies is also expected to aid in growth of the market. Forinstance, in November 2018, Novartis AG received an approval from the EuropeanCommission for its CAR-T (Kymriah) for treatment of B-cell acute lymphoblasticleukemia in pediatric and adult patients.
Global Stem Cells Market:Competitive Landscape
Major players operating in theglobal stem cells market include, Advanced Cell Technology, Inc., AngelBiotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics.,BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., CelgeneCorporation, Takara Bio Europe AB, Cellular Engineering Technologies, CytoriTherapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc.
Global Stem Cells Market: KeyDevelopments
Major players in the market arefocused on adopting collaboration and partnership strategies to expand theirproduct portfolio. For instance, in September 2020, Lineage Cell Therapeutics,Inc., ES Cell International Pte Ltd., a subsidiary of Lineage, and AgeXTherapeutics, Inc., a company focused on developing and commercializinginnovative therapeutics for human aging, announced the broadening of theircollaborative relationship with regard to ES Cell International Pte Ltd. stemcell lines.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/4222
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
